Abbott India Limited operates as a pharmaceutical company in India.
No risks detected for ABBOTINDIA from our risk checks.
Outstanding track record with flawless balance sheet and pays a dividend.
Share Price & News
How has Abbott India's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ABBOTINDIA has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ABBOTINDIA exceeded the Indian Pharmaceuticals industry which returned 47.1% over the past year.
Return vs Market: ABBOTINDIA exceeded the Indian Market which returned 2.4% over the past year.
Price Volatility Vs. Market
How volatile is Abbott India's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StEarnings Tell The Story For Abbott India Limited (NSE:ABBOTINDIA)
1 month ago | Simply Wall StWhat You Need To Know About Abbott India Limited's (NSE:ABBOTINDIA) Investor Composition
1 month ago | Simply Wall StDoes Abbott India Limited (NSE:ABBOTINDIA) Have A Place In Your Dividend Portfolio?
Is Abbott India undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ABBOTINDIA (₹16199) is trading above our estimate of fair value (₹5338.61)
Significantly Below Fair Value: ABBOTINDIA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ABBOTINDIA is poor value based on its PE Ratio (58x) compared to the IN Pharmaceuticals industry average (24.1x).
PE vs Market: ABBOTINDIA is poor value based on its PE Ratio (58x) compared to the Indian market (13.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ABBOTINDIA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ABBOTINDIA is overvalued based on its PB Ratio (14.1x) compared to the IN Pharmaceuticals industry average (2x).
How is Abbott India forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Abbott India has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out Abbott India's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Abbott India competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Abbott India performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ABBOTINDIA has high quality earnings.
Growing Profit Margin: ABBOTINDIA's current net profit margins (14.5%) are higher than last year (12.2%).
Past Earnings Growth Analysis
Earnings Trend: ABBOTINDIA's earnings have grown significantly by 20.2% per year over the past 5 years.
Accelerating Growth: ABBOTINDIA's earnings growth over the past year (31.6%) exceeds its 5-year average (20.2% per year).
Earnings vs Industry: ABBOTINDIA earnings growth over the past year (31.6%) exceeded the Pharmaceuticals industry 14.6%.
Return on Equity
High ROE: ABBOTINDIA's Return on Equity (24.4%) is considered high.
How is Abbott India's financial position?
Financial Position Analysis
Short Term Liabilities: ABBOTINDIA's short term assets (₹32.0B) exceed its short term liabilities (₹8.9B).
Long Term Liabilities: ABBOTINDIA's short term assets (₹32.0B) exceed its long term liabilities (₹2.2B).
Debt to Equity History and Analysis
Debt Level: ABBOTINDIA is debt free.
Reducing Debt: ABBOTINDIA had no debt 5 years ago.
Debt Coverage: ABBOTINDIA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ABBOTINDIA has no debt, therefore coverage of interest payments is not a concern.
What is Abbott India current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: ABBOTINDIA's dividend (1.54%) is higher than the bottom 25% of dividend payers in the Indian market (0.63%).
High Dividend: ABBOTINDIA's dividend (1.54%) is low compared to the top 25% of dividend payers in the Indian market (2.63%).
Stability and Growth of Payments
Stable Dividend: ABBOTINDIA's dividends per share have been stable in the past 10 years.
Growing Dividend: ABBOTINDIA's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (38.3%), ABBOTINDIA's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Anil Joseph (45 yo)
Mr. Anil Joseph serves as Managing Director and Director at Abbott India Limited since June 2020. He comes with an excellent track record of over 25 years working with reputable companies across different ...
|CFO, Group Finance Director & Whole-time Director||3yrs||₹30.48m||no data|
|MD & Director||0.17yr||no data||no data|
|Additional Non Executive Non Independent Director||3.92yrs||₹65.08m||no data|
|Chairman of the Board||no data||₹1.50m||no data|
|Non-Executive Director||9.42yrs||₹15.90m||no data|
|Independent Director||1.33yrs||₹5.94m||0.0012% |
|Independent Director||2.33yrs||₹1.30m||no data|
|Independent Director||0.83yr||no data||no data|
Experienced Board: ABBOTINDIA's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Abbott India Limited's company bio, employee growth, exchange listings and data sources
- Name: Abbott India Limited
- Ticker: ABBOTINDIA
- Exchange: NSEI
- Founded: 1944
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹343.996b
- Shares outstanding: 21.25m
- Website: https://www.abbott.co.in
Number of Employees
- Abbott India Limited
- Godrej BKC
- 16th Floor, Plot C, “G” Block
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|500488||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Sep 1999|
|ABBOTINDIA||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||Sep 1999|
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women’s health, gastroenterology, metabolics, central nervous sy ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/08 12:48|
|End of Day Share Price||2020/08/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.